Bioray Pharmaceutical Co., Ltd.

This is the first study in people to test a new drug called BR115 for advanced solid cancers. The main goal is to check the drug's safety, side effects, and how the body processes it, while also looking for early signs that it might help shrink tumors. It will involve about 120 a…

This study is testing if a new drug called HS627 works as well as the standard drug pertuzumab when combined with other treatments before surgery for early or locally advanced HER2-positive breast cancer. The goal is to shrink or eliminate the tumor before the operation. About 40…

This study is testing a new drug called Zuberitamab (HS006) for people with primary membranous nephropathy, a serious autoimmune kidney disease that causes protein loss. It will compare Zuberitamab to an existing drug, cyclosporine, to see which is better at reducing protein in t…